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OBJECTIVES This study sought to determine whether echocardiography before mitral valve repair (MVR)
for mitral regurgitation (MR) was predictive of postoperative left ventricular (LV) dysfunc-
tion and useful for deciding the optimal timing of repair.
BACKGROUND Some reports have shown that the preoperative echocardiographic data of left ventricular
ejection fraction (LVEF) and left ventricular end-systolic diameter (LVDs) were good
predictors of postoperative LV dysfunction. However, few reports were based on long-term
follow-up data of large numbers of patients who underwent MVR in the last decade.
METHODS A total of 274 patients with moderate or severe MR underwent MVR between October 1,
1991, and September 30, 2000. Among them, 171 patients who had both an operation for
isolated MR due to degenerative pathology and a postoperative echocardiogram were studied.
Postoperative echocardiograms were performed 3.9  2.4 years after the operation.
RESULTS The LVEF decreased from 66 10% before surgery to 63 11% after surgery (p 0.0001).
On univariate analysis, preoperative LVEF and LVDs correlated with postoperative LVEF (r
 0.41 and r  0.39, respectively). Overall, postoperative LV dysfunction (defined as
LVEF 50%) was not frequent (12%). However, the incidence of postoperative LV
dysfunction was high in patients with preoperative LVEF 55% (38%) or LVDs 40 mm
(23%).
CONCLUSIONS In patients with MR, the echocardiographic data of LVEF and LVDs were good predictors
of postoperative LV dysfunction. When a decrease in LVEF or an increase in LVDs is
detected, MVR should be considered to preserve postoperative LV function. (J Am Coll
Cardiol 2003;42:458–63) © 2003 by the American College of Cardiology Foundation
The effectiveness of mitral valve repair (MVR) for patients
with mitral regurgitation (MR) is well established (1–8).
This advent has led to earlier surgical intervention to correct
MR, because deferring surgery until the patient becomes
symptomatic or manifests overt left ventricular (LV) dys-
function often leads to irreversible LV dysfunction after the
operation (3,6,8–11).
See page 464
Some reports have shown that preoperative echocardio-
graphic data, especially left ventricular ejection fraction
(LVEF) and left ventricular end-systolic diameter (LVDs),
were good predictors of survival (12–14) and postoperative
LV dysfunction (3,5,12,13,15) and useful in clinical
decision-making on the timing of surgery. Some previous
reviews (6,8) and the American College of Cardiology/
American Heart Association (ACC/AHA) guidelines (7)
recommend MVR even without symptoms if the LVEF
falls to lower than 60% or LVDs increases to over 45 mm.
However, few reports on this issue were based on long-
term follow-up data of large series of MVR alone (excluding
valve replacement) conducted in the last decade. The
purpose of this study was to determine whether echocardio-
graphic measures were predictive of LV dysfunction after
MVR and useful in deciding the optimal timing of repair,
by analyzing a large series of patients who had the operation
in the 1990s, with relatively long-term follow-up data.
METHODS
Patients. Between October 1, 1991, and September 30,
2000, 274 patients with moderate or severe MR, age 20
years or above, with no concomitant mitral stenosis, under-
went MVR at our institution. The etiologies of regurgita-
tion are shown in Table 1. The 224 patients with regurgi-
tation due to degenerative pathology were considered
possible candidates for this study.
Among them, 23 patients were excluded because of
concomitant surgical procedures, including coronary artery
bypass grafting (n  6), aortic valve replacements or plasty
(n  12), closure of atrial septum defects (n 2), closure of
ventricular septum defects (n  2), and Bentall’s procedure
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(n  1). Those who underwent concomitant tricuspid
annuloplasty, tricuspid valve plasty, left atrial plication, or
the Maze procedure were included.
Among the remaining 201 patients, 9 (4%) were con-
firmed to be unsuitable for MVR intraoperatively and
converted to mitral valve replacement during the same
operation. First, the other 192 patients comprised our study
population for patient survival and reoperations. After
excluding those without postoperative echocardiographic
data at least six months after operation, 171 patients were
included in the analysis of postoperative LV dysfunction.
The mean age of the patients was 54 13 years (range 22
to 77 years ), and 107 (63%) were men. Before surgery, 43
patients were in New York Heart Association (NYHA)
functional class I, 84 patients were in class II, 40 were in
class III, and 4 were in class IV. Among 21 patients without
echocardiographic data at least six months after the opera-
tion, the mean age was higher (64  9 years, p  0.001),
and 9 (43%) were men. There was no significant difference
in preoperative LVEF between patients with and without
follow-up echocardiographic data (66  10% vs. 62  12%,
p  0.07).
Surgical procedures. Prolapse of the posterior leaflet was
repaired with sliding plasty or resection/suture in most
cases, and some required chordal replacement with ex-
panded polytetrafluoroethylene (ePTFE) sutures. Most
cases of prolapse of the anterior leaflet were managed with
ePTFE sutures (16). The majority of patients also had a ring
annuloplasty. Since February 1996, we have been perform-
ing physiologic remodeling annuloplasty, which we devel-
oped to retain the shape of the anterior leaflet (17). Since
1993, intraoperative transesophageal echocardiography has
been routinely performed, and repair was redone when more
than mild regurgitation was detected.
Echocardiographic examinations. Postoperative echocar-
diographic examinations were performed during a follow-up
period of 3.9  2.4 years after the operation. For those
patients who died or underwent reoperation during the
follow-up period, the latest echocardiographic data before
death or the secondary surgical intervention was used. The
LVEF was calculated by the Teichholz formula from
M-mode recordings (18).
Statistical analysis. All data are expressed as means  SD.
A comparison of variables between patients with and
without follow-up echocardiographic data and variables
before and after MVR was performed by the Student paired
t test. The survival rate and survival free of reoperation were
estimated by the Kaplan-Meier method. Simple linear
regression analysis was used to determine the relationship
between preoperative clinical or echocardiographic variables
and postoperative LVEF. Stepwise selection multiple re-
gression analysis was used to study multivariate models to
predict a postoperative LVEF with significant univariate
predictors, with the criterion for inclusion being p  0.20.
The Mann-Whitney U test was used to compare the
incidence of LV dysfunction according to more than two
classes of preoperative variables. The difference in the
incidence between two groups was evaluated using the
Fisher exact test. Logistic regression analysis was used to
predict postoperative LV dysfunction with preoperative
echocardiographic variables. All comparisons were
two-tailed.
Table 1. Etiologies of Mitral Regurgitation Among 274 Patients





Dilated cardiomyopathy 4 (1)






*Including fibroelastic deficiency, billowing valves, and healed infective endocarditis.
Data are presented as the number (%) of patients.
Re-MVP  secondary repair after the previous mitral valve repair.
Table 2. Changes of Echocardiographic Data Before and After
Mitral Valve Repair Among 171 Patients
Preoperative Postoperative p Value
LVDd (mm) 61  7 51  7 0.0001
LVDs (mm) 38  7 33  8 0.0001
LVEF (%) 66  10 63  11 0.0001
Data are presented as the mean  SD.
LVDd  left ventricular end-diastolic diameter; LVDs  left ventricular end-
systolic diameter; LVEF  left ventricular ejection fraction.
Table 3. Univariate Correlation of Postoperative Ejection Fraction
With Preoperative Clinical or Echocardiographic Variables
r Value p Value
Age at operation (yrs) 0.09 0.22
Preoperative NYHA
Class I or not 0.02 0.82
Class II or not 0.02 0.80
Class III or not 0.02 0.81
Preoperative LVEF (%) 0.41 0.0001
Preoperative LVDs (mm) 0.39 0.0001
Preoperative LVDd (mm) 0.20 0.008
NYHA  New York Heart Association; other abbreviations as in Table 2.
Abbreviations and Acronyms
ACC/AHA  American College of Cardiology/
American Heart Association
ePTFE  expanded polytetrafluoroethylene
LV  left ventricle/ventricular
LVDd  left ventricular end-diastolic diameter
LVDs  left ventricular end-systolic diameter
LVEF  left ventricular ejection fraction
MR  mitral regurgitation
MVR  mitral valve repair
NYHA  New York Heart Association
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RESULTS
Patient survival and reoperations. Among the 192 pa-
tients, 14 died during the follow-up period of 4.1  2.5
years. Five patients died before being discharged within 90
days after the procedures: four due to pneumonia and one
due to septic shock. Nine late deaths occurred: five due to
cerebrovascular disease, two due to congestive heart failure,
and two due to malignant disease. The survival rate after
MVR was 97% at one year and 92% at five years. In
addition, three patients required secondary MVR, and eight
patients underwent mitral valve replacement during the
follow-up period. Survival free of reoperation was 99% at
one year and 94% at five years.
Comparison of preoperative and postoperative echocar-
diographic variables. After MVR, both LVDd and LVDs
decreased significantly (Table 2). The decrease was much
greater for LVDd than for LVDs; thus, the LVEF also
decreased significantly from 66  10% to 63  11% (p 
0.0001).
Univariate associations between preoperative echocar-
diographic variables and postoperative LVEF. On uni-
variate analysis, the preoperative LVEF was most predictive
of postoperative LVEF (Table 3, Fig. 1). Preoperative
LVDs also significantly correlated with postoperative LVEF
(Fig. 2). The univariate correlation between preoperative
LVDd and postoperative LVEF was weaker (Fig. 3). There
was no significant relationship between the age at operation
or NYHA class and postoperative LVEF.
Multivariate associations between preoperative echocar-
diographic variables and postoperative LVEF. Multiple
regression analysis with preoperative echocardiographic
variables was performed to predict a postoperative LVEF.
The two best models were:
Post LVEF 44 (0.44 pre-LVEF) (0.17 pre-LVDd)
(R2  0.179, p  0.0001) and
Post LVEF 51 (0.32 pre-LVEF) (0.25 pre-LVDs)
(R2  0.175, p  0.0001)
Figure 1. Correlation between preoperative and postoperative left ventricular ejection fraction (LVEF).
Figure 2. Correlation between preoperative left ventricular end-systolic diameter (LVDs) and postoperative left ventricular ejection fraction (LVEF).
460 Matsumura et al. JACC Vol. 42, No. 3, 2003
Prediction of LV Dysfunction After MVR August 6, 2003:458–63
where “post” and “pre” represent “postoperative” and “pre-
operative,” respectively.
Although univariate analysis showed that preoperative
LVDs was more predictive than preoperative LVDd, the
model with preoperative LVEF and LVDd had a little
higher coefficient of determination than the model with
preoperative LVEF and LVDs. This is mainly because a
higher correlation coefficient between preoperative LVEF
and LVDs (r  0.81) reduces the additional predictive
value of LVDs in relation to LVEF, and this does not
necessarily mean that LVDd is a better predictor than
LVDs.
Incidence of postoperative LV dysfunction. The overall
postoperative LV dysfunction (defined as LVEF 50%)
was not frequent (12%). However, among patients with a
low LVEF before surgery, the incidence of postoperative
LV dysfunction was higher (p  0.0013, Table 4). Simi-
larly, those with a larger LVDs before surgery had a
tendency to have LV dysfunction after surgery (p  0.006,
Table 5).
Table 6 shows that patients with an LVEF 55% or an
LVDs 40 mm before surgery had a higher risk of LV
dysfunction after surgery (p  0.0007 or p  0.0019,
respectively). Even with a preoperative LVEF 55%, 14%
of patients had postoperative LV dysfunction when their
preoperative LVDs was 40 mm or above, although logistic
regression analysis showed no significant additional predic-
tive value of preoperative LVDs 40 mm with LVEF
55%, compared with LVEF55% alone, with a relatively
low p value (p  0.1282).
DISCUSSION
In chronic MR, increased preload and reduced afterload due
to unloading from the LV into the left atrium facilitate LV
ejection. Therefore, the LVEF is maintained in the lower
normal range, and patients remain in an asymptomatic state
even in the presence of LV dysfunction (7,9). Thus, defer-
ring surgical intervention for too long often leads to irre-
versible postoperative LV dysfunction (3,6,8–11).
Previous reports have shown that NYHA classification
was a good predictor of postoperative survival (14,19) and
myocardial failure (3,5). However, the evaluation is subjec-
tive, and many people feel only mildly symptomatic because
they limit their own activity unconsciously. Thus, a nonin-
vasive and objective echocardiographic examination, which
can be done repeatedly, is needed to guide the optimal
timing of surgical intervention. Moreover, to determine the
timing, we must take into consideration not only postoper-
ative survival but also the incidence of postoperative LV
dysfunction. It may be a matter of controversy whether a
patient who has slight LV dysfunction but becomes asymp-
tomatic should be recognized to have a bad clinical out-
come. However, we studied objective postoperative echo-
cardiographic data, not subjective postoperative symptoms,
as the major measure of outcome.
Table 4. Incidence of Postoperative LV Dysfunction According to Classes of Preoperative LVEF
Preoperative LVEF (%) <50 <55 <60 >60 Total
Postoperative LVEF 50% (n) 5 3 2 10 20
Postoperative LVEF 50% (n) 4 9 20 118 151
Total (n) 9 12 22 128 171
Incidence of LV dysfunction* (%) 56 25 9 8 12
*Defined as LVEF 50%.
LV  left ventricular; LVEF  left ventricular ejection fraction.
Figure 3. Correlation between preoperative left ventricular end-diastolic diameter (LVDd) and postoperative left ventricular ejection fraction (LVEF).
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Enriquez-Sarano et al. (15) studied 162 patients with
MVR and 104 patients with mitral valve replacement
between 1980 and 1989. They reported that preoperative
LVEF and LVDs were independent predictors of postop-
erative LVEF and that surgical correction should be
strongly considered in patients with an LVEF 60% or
with an LVEF over 60% and an LVDs approaching 45 mm.
In another study of 288 patients with MVR and 288
patients with valve replacement, they concluded that the
incidence of congestive heart failure was very high in
patients with an LVEF 50% and that the incidence was
also increased in patients with an LVEF between 50% and
59% (3). Lee et al. (5) studied 167 patients with MVR and
111 patients with mitral valve replacement between 1987
and 1994 and reported that the risk of postoperative
myocardial failure was markedly increased when the preop-
erative LVEF was 40%. In a study of 61 patients with
rheumatic MR who were followed up after mitral valve
replacement, Wisenbaugh et al. (13) reported that a good
outcome was predicted at a preoperative LVDs of 40 mm.
Flemming et al. (20) found in a study of 27 patients that an
LVDs over 40 mm might be useful for identifying patients
with MR and occult LV dysfunction.
However, among the aforementioned studies that exam-
ined whether echocardiographic data were predictive of
postoperative LV dysfunction, some were based on series
composed entirely (12,13) or partially (3,5,15,20) of mitral
valve replacement or patients who had an operation in the
1980s (3,15). Others were based on data with a mean
follow-up period less than two years (12,20) or data from a
small number of patients (12,13,20). The feature of this
study is its longer follow-up data of a larger series of MVR
conducted in the 1990s.
In our institute, most patients with degenerative MR who
need surgical intervention undergo MVR, even with pro-
lapse of the anterior leaflet. Our series showed excellent
mid-term results with a good survival rate and survival free
of reoperation after MVR.
In the present study, LVDs decreased significantly after
surgery, which would imply increased contractility, de-
creased afterload, or both. Postoperative afterload usually
increases with correction of MR, and decreased LVDs is
considered to reflect increased LV contractility. The LVEF
decreased significantly after surgery, which is consistent
with previous studies (4,15). The decrease must be due
mainly to a decrease in preload after surgical correction of
MR and does not necessarily indicate true impairment of
LV systolic performance.
The overall frequency of postoperative LV dysfunction
was relatively low (12%) in our series. This may be the result
of advances in surgical techniques and the earlier timing of
operations at our institute. However, the patients with a
lower LVEF or larger LVDs before surgery tended to have
postoperative LV dysfunction. In particular, those with
LVEF 55% or LVDs 40 mm before surgery had a
significantly higher incidence of LV dysfunction after sur-
gery.
Symptomatic patients refractory to appropriate medical
therapy obviously require surgery even when LV function is
apparently normal (3,5,6,8,14,18,21). In addition, our study
suggests that patients with LVEF55% or LVDs40 mm
are also candidates for repair, considering the lower opera-
tive mortality rate in recent years (4,19,22,23). Furthermore,
the advances of transthoracic and transesophageal echocar-
diography have made it easy to determine the feasibility of
valve repair before surgery.
We found that an LVEF of 55% and an LVDs of 40 mm
identified Japanese patients with a higher risk of postoper-
ative LV dysfunction, and both values were lower than those
recommended in the ACC/AHA guidelines (7). These
echocardiographic measures in Japanese patients may not be
applied directly to patients in other countries, because the
normal size of the heart may be different. Nevertheless,
these data collectively confirm that the echocardiographic
data on LVEF and LVDs are good predictors of postoper-
ative LV dysfunction and are useful in deciding the optimal
timing of MVR.
Study limitations. In this study, we defined LV dysfunc-
tion as LVEF 50%, according to Enriquez-Sarano et al.
(15). However, postoperative LV performance is not deter-
mined by LVEF alone. We studied postoperative LVEF,
which was easy to measure, but it is only one aspect of LV
Table 5. Incidence of Postoperative LV Dysfunction Stratified by Preoperative LVDs
Preoperative LVDs (mm) <30 <35 <40 <45 >45 Total
Postoperative LVEF 50% (n) 1 4 3 5 7 20
Postoperative LVEF 50% (n) 15 48 54 18 16 151
Total (n) 16 52 57 23 23 171
Incidence of LV dysfunction* (%) 6 8 5 22 30 12
*Defined as LVEF 50%.
Abbreviations as in Tables 2 and 4.
Table 6. Incidence of Postoperative LV Dysfunction According to





40 None* 7/115 (6%) 7/115 (6%)
40 8/21 (38%) 5/35 (14%) 13/56 (23%)‡
Total 8/21 (38%)† 12/150 (8%) 20/171 (12%)
*No patient was categorized into this group. †p  0.0007 versus preoperative LVEF
55%. ‡p 0.0019 versus preoperative LVDs40 mm. Left ventricular dysfunction
was defined as LVEF 50%.
Abbreviations as in Tables 2 and 4.
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performance. We did not take into account the effect of
medications that reduce LV contractility and the influence
of residual MR.
In addition, we included only those patients with degen-
erative mitral valve disease. Patients with MR due to
rheumatic disease are usually less feasible for MVR and
more likely to require conversion to mitral valve replacement
intraoperatively, even though MVR is expected preopera-
tively. Also, their LV performance after valve repair is less
known. It is still controversial as to when to recommend
surgery for an asymptomatic patient with a rheumatic valve
that is expected to be repairable.
Conclusions. Our study of a large series of patients who
had an operation in the 1990s, with long-term follow-up
data, shows that the echocardiographic parameters of LVEF
and LVDs are good predictors of postoperative LV dysfunc-
tion and useful as objective markers to decide the timing of
surgery. Considering the lower operative mortality rate in
recent years, when a slight decrease in LVEF or a slight
increase in LVDs is detected on an echocardiogram of a
patient with degenerative MR, early surgical intervention
with MVR should be considered to preserve LV function
after surgery.
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